These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34857588)

  • 21. Gene therapy for cystic fibrosis: new tools for precision medicine.
    Lee JA; Cho A; Huang EN; Xu Y; Quach H; Hu J; Wong AP
    J Transl Med; 2021 Oct; 19(1):452. PubMed ID: 34717671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evidence-based treatment of cystic fibrosis].
    Ringshausen FC; Hellmuth T; Dittrich AM
    Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis.
    Liu Z; Anderson JD; Deng L; Mackay S; Bailey J; Kersh L; Rowe SM; Guimbellot JS
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32485957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor.
    Ziady AG; Kelley TJ; Milliken E; Ferkol T; Davis PB
    Mol Ther; 2002 Apr; 5(4):413-9. PubMed ID: 11945068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis.
    Robinson E; MacDonald KD; Slaughter K; McKinney M; Patel S; Sun C; Sahay G
    Mol Ther; 2018 Aug; 26(8):2034-2046. PubMed ID: 29910178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlating genotype with phenotype using CFTR-mediated whole-cell Cl
    Noel S; Servel N; Hatton A; Golec A; Rodrat M; Ng DRS; Li H; Pranke I; Hinzpeter A; Edelman A; Sheppard DN; Sermet-Gaudelus I
    J Physiol; 2022 Mar; 600(6):1515-1531. PubMed ID: 34761808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis precision therapeutics: Emerging considerations.
    Joshi D; Ehrhardt A; Hong JS; Sorscher EJ
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3(Suppl 3):S13-S17. PubMed ID: 31715091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in cystic fibrosis personalised epithelial assays: Science and patient perspectives.
    Kaiko GE; Wark PAB
    J Cyst Fibros; 2018 May; 17(3):289-291. PubMed ID: 29661511
    [No Abstract]   [Full Text] [Related]  

  • 29. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
    Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.
    McCague AF; Raraigh KS; Pellicore MJ; Davis-Marcisak EF; Evans TA; Han ST; Lu Z; Joynt AT; Sharma N; Castellani C; Collaco JM; Corey M; Lewis MH; Penland CM; Rommens JM; Stephenson AL; Sosnay PR; Cutting GR
    Am J Respir Crit Care Med; 2019 May; 199(9):1116-1126. PubMed ID: 30888834
    [No Abstract]   [Full Text] [Related]  

  • 31. Personalised medicine in advanced cystic fibrosis.
    McKone EF
    Lancet Respir Med; 2016 Aug; 4(8):594-595. PubMed ID: 27298016
    [No Abstract]   [Full Text] [Related]  

  • 32. Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator.
    Villamizar O; Waters SA; Scott T; Grepo N; Jaffe A; Morris KV
    J Extracell Vesicles; 2021 Jan; 10(3):e12053. PubMed ID: 33532041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator.
    Villamizar O; Waters SA; Scott T; Saayman S; Grepo N; Urak R; Davis A; Jaffe A; Morris KV
    Mol Ther; 2019 Oct; 27(10):1737-1748. PubMed ID: 31383454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
    Johnson LG; Boyles SE; Wilson J; Boucher RC
    J Clin Invest; 1995 Mar; 95(3):1377-82. PubMed ID: 7533790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing.
    Song Y; Lou HH; Boyer JL; Limberis MP; Vandenberghe LH; Hackett NR; Leopold PL; Wilson JM; Crystal RG
    Hum Gene Ther; 2009 Mar; 20(3):267-81. PubMed ID: 19257851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
    Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
    J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.
    Derichs N
    Eur Respir Rev; 2013 Mar; 22(127):58-65. PubMed ID: 23457166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.